Cargando...
Medical therapy doses at hospital discharge in patients with existing and de novo heart failure
AIMS: Uptitrating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers (ACE‐I/ARBs), beta‐blockers, and mineralocorticoid receptor antagonists (MRAs) to optimal doses in heart failure with reduced ejection fraction (HFrEF) is associated with improved outcomes and recommended in...
Gardado en:
| Publicado en: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676447/ https://ncbi.nlm.nih.gov/pubmed/31218850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12454 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|